NorDocs Technologies to Present at the Neurotech Investing & Partnering Conference
Ottawa, Ontario—March 18, 2013—NorDocs Technologies announced today that the company will be presenting at the Neurotech Investing & Partnering Conference in San Francisco, California. The Neurotech Investing & Partnering Conference runs from May 23rd to 24th and Stanley Shapiro, MD, Co-founder and CEO, will be presenting on behalf of NorDocs.
“It’s an honour to be part of this important event,” said Dr. Shapiro. “This conference is an excellent opportunity for NorDocs to collaborate with leaders in the neurotechnology industry. We look forward to connecting with other professionals from the space and learning about new innovations in neurotechnology.ˮ
The Neurotech Investing & Partnering Conference will bring together experts in all areas of the neurotechnology industry including pharmaceuticals, medical devices and diagnostics. The goal of the conference is to bring together investors, executives, entrepreneurs, scientists and all involved in the development of new treatments and diagnostics. Conference highlights will include emerging technologies and companies, cutting edge research and funding opportunities, and the next generation of treatments.
“NorDocs is an great example of the novel neurotechnology that will be presented at Neurotech 2013,” said Casey Lynch, Managing Director of NeuroInsights, Director of the Neurotechnology Industry Organization, and conference Chairperson. “Our goal is to give investors and partners a first-hand view of the most exciting developments across neurotech and an opportunity to meet with the CEOs on a one to one basis to get deals done that will speed the delivery of critical new therapies to patients suffering from brain and nervous system illnesses.”
To learn more about the Neurotech Investing & Partnering Conference in San Francisco please visit http://www.
About NorDocs: NorDocs was founded by addiction medicine physicians with the purpose of finding a better way to address key challenges in the field of addiction. The company has focused its efforts on the development of a non-invasive neurostimulation platform and the protocols for specific medical indications, beginning with the nicotine and narcotics addictions. NorDocs currently offers a smoking cravings program to smoking clinics and will be offering a smoking cessation treatment program following medical device license approval later this year. Located in Sudbury, Ontario with R&D in Ottawa, Ontario, NorDocs currently sells directly to smoking clinics in Canada and is in the process of developing international distribution partners.
To learn more about NorDocs Technologies please visit www.NorDocs.com
Press contact:
Steven Tover
VP Business Development, NorDocs Technologies
Inquiries by email: steve@nordocs.com
Inquiries by phone: 613-454-1228 ext 2
Comments are closed.